Relapse Prevention With Escitalopram or Nortriptyline Following Electro-Convulsive Treatment (DUAG-7)
Status:
Terminated
Trial end date:
2014-11-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to investigate the relapse preventing efficacy of
escitalopram in a dose range and nortriptylin in a single dose in patients having been
treated successfully with a course of electroconvulsive treatment (ECT).